Why the study?
Does chelation therapy with edetic acid (EDTA) treat coronary atherosclerosis?
Does chelation therapy with edetic acid (EDTA) treat coronary atherosclerosis?
EDTA chelation therapy lacks efficacy for treating coronary atherosclerosis and its use should be discouraged by health professionals.
Answers are grounded in this paper and cite their sources.
EDTA chelation shows no benefit in this coronary atherosclerosis case; leaves open whether RCTs could alter the observed lack of efficacy.
Patients diagnosed with incurable or fatal diseases may seek alternatives to standard medical therapy and spend significant amounts of money for these therapies. One alternative medical therapy, chelation therapy with edetic acid (EDTA), has gained considerable popularity for the alleged treatment of atherosclerotic vascular disease; however, its efficacy for this indication remains unproven and its use is controversial. We present a case in which chelation therapy was unsuccessful in treating coronary atherosclerosis and review reports that substantiate a lack of efficacy using chelation therapy in the treatment of coronary atherosclerosis. Treatment of atherosclerotic-related diseases using chelation therapy should be discouraged by health professionals. Patients should be counseled regarding the risk of improper diagnosis and treatment of their disease.
No takes yet. Share an insight, caveat, or question.
Wirebaugh et al. (1990) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: